1. Home
  2. FCBC vs OCS Comparison

FCBC vs OCS Comparison

Compare FCBC & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Community Bankshares Inc. (VA)

FCBC

First Community Bankshares Inc. (VA)

N/A

Current Price

$48.50

Market Cap

911.3M

Sector

Finance

ML Signal

N/A

Logo Oculis Holding AG Ordinary shares

OCS

Oculis Holding AG Ordinary shares

N/A

Current Price

$12.06

Market Cap

732.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FCBC
OCS
Founded
1874
2003
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
911.3M
732.4M
IPO Year
1996
2022

Fundamental Metrics

Financial Performance
Metric
FCBC
OCS
Price
$48.50
$12.06
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$42.00
AVG Volume (30 Days)
63.7K
170.1K
Earning Date
04-28-2026
05-07-2026
Dividend Yield
5.26%
N/A
EPS Growth
N/A
N/A
EPS
1.82
N/A
Revenue
N/A
N/A
Revenue This Year
$12.28
$466.06
Revenue Next Year
$2.55
$479.73
P/E Ratio
$26.76
N/A
Revenue Growth
N/A
N/A
52 Week Low
$31.21
$10.52
52 Week High
$50.17
$34.48

Technical Indicators

Market Signals
Indicator
FCBC
OCS
Relative Strength Index (RSI) 57.62 39.19
Support Level $47.54 $10.63
Resistance Level $49.84 $13.28
Average True Range (ATR) 0.91 0.39
MACD -0.18 -0.09
Stochastic Oscillator 61.25 6.57

Price Performance

Historical Comparison
FCBC
OCS

About FCBC First Community Bankshares Inc. (VA)

First Community Bankshares Inc is a financial holding company that provides commercial banking products and services. The company is engaged in providing demand deposit accounts, savings, and money market accounts, certificates of deposits; commercial, consumer, and real estate mortgage loans, and lines of credit; various credit card, debit card, and automated teller machine card services; corporate and personal trust services; investment management services and life, health, and property and casualty insurance products. The company's revenue is mainly derived from interest, fees, and commissions.

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.

Share on Social Networks: